Skip to main content
. 2023 Apr 24;14:1143548. doi: 10.3389/fimmu.2023.1143548

Table 2.

Methods applied to assess the intestinal barrier function and the efficacy of probiotics.

Methods Number Studies Participants Mean difference
(95% CI)
P - value Heterogeneity
L/M 8 18, 22, 26, 28, 29, 33, 35, 36 517 -0.02 [-0.03, 0.00] P = 0.06 I2 =  87%
Fecal Zonulin 5 22, 23, 25, 38, 42 190 -1.63 [-14.06, 10.81] P = 0.80 I2 =  50%
Serum Zonulin 5 22, 27, 29, 40, 42 385 -1.58 [-2.49, -0.66] P = 0.0007 I2 =  92%
ET 4 27, 38, 44, 45 219 -3.20 [-5.41, -0.98] P = 0.005 I2 =  97%
DAO 5 23, 26, 38, 41, 45 268 -0.31 [-1.03, 0.40] P = 0.39 I2 =  86%
L/R 4 30, 31, 34, 42 143 -0.04 [-0.13, 0.04] P = 0.33 I2 =  97%
TER 3 21, 28, 29 170 5.27 [3.82, 6.72] P < 0.00001 I2 =  0%
LPS 3 34, 39, 41 113 -0.47 [-0.85, -0.09] P = 0.02 I2 =  48%
D-LA 2 44, 45 150 -1.95 [-4.57, 0.68] P = 0.15 I2 =  98%
I-FABP 2 19, 28 187 67.93 [3.43, 132.43] P = 0.04 I2 =  72%
Fecal calprotectin 2 23, 38 89 31.78 [-138.88, 202.45] P = 0.72 I2 =  65%
LBP 2 23, 38 89 0.10 [-0.31, 0.52] P = 0.63 I2 =  0%
HRP 2 28, 29 250 -0.54 [-0.60, -0.49] P < 0.00001 I2 =  0%
S/E 1 42 25 0.01 [0.00, 0.02] P = 0.01 Not applicable
Mannitol permeability 1 21 60 -0.74 [-0.87, -0.61] P < 0.00001 Not applicable
PEGs 1 19 67 0.11 [-0.95, 1.17] P = 0.84 Not applicable
Saccharose recovery 1 26 28 -0.30 [-0.56, -0.04] P = 0.03 Not applicable
ZO-1 1 39 36 -0.29 [-0.75, 0.17] P = 0.22 Not applicable
NO 1 19 94 214.06 [56.03, 372.09] P = 0.008 Not applicable

L/M, lactulose/mannitol; L/R, lactulose/rhamnose; S/E, sucralose/erythritol; PEGs, polyethylene glycols; D-LA, D-lactic acid; TER, transepithelial electrical resistance; ZO-1, zonula occluden-1; I-FABP, intestinal fatty acid binding protein; NO, nitric oxide; ET, endotoxin; LPS, lipopolysaccharide; LBP, lipopolysaccharide binding protein; HRP, horseradish peroxidase; DAO, diamine oxidase.